| Wockhardt gets FDA nod for Nicardipine injections | 18-NOV-09 |
|
| Drug firm Wockhardt today said it has received the final approval from the US Food and Drug Administration (FDA) for marketing Nicardipine HCI injections in 25mg/10 ml strength, used in the treatment of hypertension. |
|
|
|
|
|
|
| Glenmark Generics gets US FDA nod for Ciclopirox Olamine | 14-NOV-09 |
|
| Glenmark Generics today said it has received ANDA (abbreviated new drug application) approval from the United States Food and Drug Administration for Ciclopirox Olamine cream, used in the treatment of dermatological infections. |
|
|
|
| Venus Remedies bags patent for Potentox in SA | 12-NOV-09 |
|
| Venus Remedies has bagged patent for Potentox drug from South African patent controller. This is the company’s third product patent in South Africa this year. Companies Intellectual Property Registration Office, South Africa, has granted the company patent of two more drugs – Sulbactomax and Tobracef. |
|
|
|
| MNCs working against Indian drug firms: Sharma to WIPO | 11-NOV-09 |
|
| India today complained to the UN intellectual property rights body, WIPO, that some multinational firms have launched campaign against country's pharmaceutical industry, which has broken their "cartel" in the generic drugs. |
|
|
|
|
|
|
|
|
|
|
|
|
| Pharma ind seeks govt assistance on takeover concerns | 06-NOV-09 |
|
| Concerned over the recent takeover of some firms by Multi National Companies (MNCs), the domestic pharmaceutical industry has asked the government to protect and promote it by making available funds for research and development. |
|
|
|
|
|
|
| Ranbaxy-Daiichi working on 3-yr plan for synergy | 28-OCT-09 |
|
| Ranbaxy Laboratories and its Japanese parent Daiichi Sankyo are working on a three-year plan for exploiting synergies in operations to enhance their generic as well as branded business across the globe. |
|
|
|
| Merck acquires bioscience company Genei | 13-OCT-09 |
|
| Pharma company Merck KGaA today said it has acquired Bangalore based Genei (India) Private by its wholly-owned Indian subsidiary, Merck Specialities. |
|
|
|
|
|
|
| Glenmark Generics files IPO prospectus with Sebi | 30-SEP-09 |
|
| Drug maker Glenmark Pharmaceuticals today said its subsidiary Glenmark Generics has filed the draft prospectus with marker regulator Securities and Exchange Board of India (SebiI) for an initial public offer (IPO). |
|
|
|
| Dr Reddy's recalls four products from US market | 30-SEP-09 |
|
| Hyderabad-based drug firm Dr Reddy's Laboratories (DRL) today said it is recalling four of its drugs used in the treatment of ailments such as allergy, depression and high cholesterol from the US market. |
|
|
|
Content Guide
